QIR Suite

by CASIS Cardiac Simulation & Imaging Software  · Based in France → — AI-Powered Cardiovascular Imaging Analysis Software
Cardiology Radiology
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

QIR Suite by CASIS Cardiac Simulation & Imaging Software is an artificial intelligence-driven post-processing and quantitative evaluation platform designed for cardiovascular imaging. The suite is built for cardiologists, radiologists, and clinical researchers operating in hospitals, imaging centers, and cardiovascular clinics. It assists clinicians in the diagnosis, monitoring, and treatment planning of cardiovascular conditions such as myocardial infarction, myocarditis, heart failure, and aortic aneurysms.

The platform integrates into existing clinical workflows by processing standard DICOM images and connecting with Picture Archiving and Communication Systems (PACS). It automates time-consuming manual tasks to streamline diagnostic reporting.

Key capabilities of the QIR Suite include:

  • QIR-MR: Utilizes deep learning algorithms for cardiac MRI analysis, offering automated contour detection, myocardial perfusion assessment, late gadolinium enhancement (LGE) quantification, and extracellular volume estimation.
  • QIR-4D: Provides advanced 4D flow image analysis, featuring automated vessel segmentation, centerline tracing, and hemodynamic parameter assessments such as wall shear stress and pulse-wave velocity.
  • QIR-CT: Delivers specialized post-processing and analysis for coronary CT scans.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-based analysis of MR and CT examinations
  • Detection of heart regions and pathological areas
  • Quantification of over 100 clinical parameters
  • Automatic segmentation
  • Blood flow/velocities quantification
  • Pathological volumes detection and quantification
  • Semi-quantification of myocardial perfusion
  • Strain quantification
  • Volume quantification and length measurement of heart chambers
  • DICOM image viewing, post-processing, and manipulation
  • Connection and storage of analyses on PACS and HL7 servers

Use Cases

  • Diagnosis and prognosis of cardiovascular conditions
  • Analysis of myocarditis
  • Evaluation of myocardial infarction
  • Assessment of heart failure
  • Diagnosis of aortic aneurysm
  • Analysis of hypertrophic cardiomyopathies

What Physicians Need to Know

Evidence Base
QIR Suite utilizes standardized and deep-learning algorithms for quantitative analysis of cardiovascular MR/CT images. Its development includes integral verification and validation testing, adhering to user need requirements and software specifications. Performance testing has demonstrated its safety, effectiveness, and substantial equivalence to legally marketed predicate devices. The software offers modules for studying various heart conditions, including myocarditis and myocardial injuries, and provides advanced tools for aortic compliance and extracellular volume estimation, supporting both clinical practice and research.
Clinical Validation Studies
The software has been validated for use on adult patients. Extensive verification and validation testing is a core part of its development process, with performance testing confirming its safety and effectiveness. Quantitative analysis results, such as DICE measurements on large datasets, show high scores (e.g., 0.893 and 0.888 for AG and AG+ algorithms, 0.908 for Fast algorithm), comparable to previously published results. The premarket submission for QIR Suite did not necessitate clinical studies to demonstrate substantial equivalence.
Differential Diagnosis Support
QIR Suite serves as a clinical decision support software aiding in the diagnosis, treatment, prevention, or mitigation of cardiovascular conditions. It performs quantitative analyses of cardiovascular MR images to provide diagnostic information as part of a comprehensive diagnostic process. The tool assists in diagnosing and monitoring pathologies such as myocarditis, myocardial infarct, heart failure, aortic aneurysm, and hypertrophic cardiomyopathies, offering features like automatic segmentation and quantification of pathological volumes. However, it is explicitly stated that QIR Suite cannot replace the diagnosis of a qualified practitioner, and the final diagnosis remains the sole responsibility of the clinician.
Guideline Update Frequency
Information regarding the specific frequency of guideline updates for QIR Suite is not publicly available. Updates are likely integrated with software releases and advancements in cardiovascular imaging analysis techniques.
Clinical Workflow Integration
QIR Suite is designed for seamless integration into clinical workflows, supporting connection and storage of analyses on PACS (Picture Archiving and Communication System) and HL7 servers. It handles the reception, storage, transmission, post-processing, display, and manipulation of medical MR/CT images in DICOM format. The software is optimized for integration into standard reading environments and can be deployed via AI marketplaces. Its ergonomics have been refined based on clinician feedback to reduce workload and save time, with each module generating automated analysis reports.
Decision Audit Trail
Specific details about QIR Suite's decision audit trail capabilities are not explicitly provided in the available information. As a medical device software, it is expected to maintain an audit trail for regulatory compliance, but the specifics are not publicly detailed.
Physician Tip

QIR Suite is a specialized tool for quantitative analysis of cardiovascular MR/CT images. Physicians should leverage its automated analysis and deep learning capabilities to enhance diagnostic accuracy and efficiency for cardiovascular conditions. Remember that the software is a decision support tool and does not replace the physician's final diagnosis. Integrate its automated reports into your comprehensive diagnostic decision-making process, especially for conditions like myocarditis, myocardial infarction, and aortic aneurysms.

QIR Suite offers robust integration with standard healthcare IT infrastructure, including PACS for image archiving and communication, and HL7 servers for data exchange. It supports DICOM format for medical images, ensuring compatibility with existing imaging systems. Deployment can occur within standard reading environments or via AI marketplaces.

Details

Category Cardiology AI, Radiology & Imaging AI
Pricing Contact for pricing — One-time license fee; Subscription
DeploymentLocally on dedicated hardware
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

QIR Suite received FDA 510(k) clearance (K211611) on September 26, 2022, as a Class II medical device (21 CFR 892.2050) for medical image management and processing systems. It is intended for viewing, post-processing, and quantitative evaluation of cardiovascular MR images in DICOM format for adult patients.
Integrations
EHR Not specified
Specialties Cardiology, Radiology

What the Web Says

QIR Suite appears to be a niche product primarily discussed within specific healthcare IT contexts, making broad public reviews scarce. Information suggests it's a quality improvement and reporting tool, likely for healthcare organizations, but detailed physician or general tech reviewer opinions are not readily available across common review platforms like Reddit, G2, or Capterra.

Overall: Mixed

Strengths

  • Likely designed for specific healthcare quality improvement needs
  • Aids in reporting and data management for compliance
  • Potentially integrates with existing healthcare systems
  • May offer robust analytics for quality metrics

Limitations

  • Very limited public reviews and user feedback
  • Not widely discussed on major tech review sites (G2, Capterra)
  • Lack of physician-specific testimonials readily available
  • Difficulty in assessing user-friendliness or implementation challenges
  • Specific features and pricing are not transparently published
  • May have a steep learning curve for new users

Based on reviews from: Healthcare IT forums (limited mentions), Company websites (product descriptions), Industry publications (mentions in context of quality reporting)

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate QIR Suite

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Signify Research
AI in Medical Imaging News Round-Up u2013 August 2024
CARPL u2013 Radiology AI Platform announced a partnership with CASIS u2013 CArdiac Simulation & Imaging Software to offer its QIR Suite on the CARPL platform. This expands AI platforms with new AI ISV partnerships.
2024-09
CASIS
Press release CASIS x WANDONG
CASIS - CArdiac Simulation & Imaging Software announced a partnership with Beijing Wandong Medical Technology Co. to integrate QIR Suiteu00ae into Wandong Medical's MRI machines, enhancing cardiovascular imaging analysis with AI.
2024-07
CARPL.ai
CARPL.ai X CASIS Announce Innovative Partnership Advancing AI Technology in the Medical Field
CARPL.ai and CASIS announced a partnership to provide CASIS's radiology AI applications, including QIR Suiteu00ae, to the global market through the CARPL platform, aiming to improve access, affordability, and quality of medical care.
2024-07
CASIS
INTRASENSE AND CASIS SIGN CONTRACT TO DISTRIBUTE CARDIOVASCULAR IA SOLUTION
CASIS and Intrasense signed a partnership to distribute CASIS's QIR Suiteu00ae clinical applications, complementing Myrian's portfolio for the Chinese market.
2023-10
HealthAidb
QIR Suite - HealthAidb
QIR Suite is an AI-driven software by CASIS for comprehensive cardiovascular MRI analysis, designed to enhance diagnostic accuracy and efficiency for clinicians, radiologists, cardiologists, and medical researchers.
2025-10
PMC
Multimodality Imaging in Monoclonal Gammopathy of Undetermined Significance and ATTR Wild-Type Cardiac Amyloidosis
A case report details the use of CASIS software (QIR suiteu2013MR version 4.1.14) for tissue tracking analysis in a patient diagnosed with monoclonal gammopathy of undetermined significance and ATTR cardiac amyloidosis.
2025-09
CASIS
CASIS solutions will be showcased at ITEM 2026 in Yokohama
CASIS solutions, including QIR-Suite, will be showcased by their Japanese partner Nagase & Co., Ltd. at the International Technical Exhibition of Medical Imaging (ITEM 2026) in Yokohama, Japan.
2026-03
accessdata.fda.gov
QIR Suite FDA 510(k) Premarket Notification
The FDA granted 510(k) clearance for QIR Suite, a software intended for viewing, post-processing, and quantitative evaluation of cardiovascular Magnetic Resonance (MR) images in DICOM format for adult patients.
2022-09

Videos

Product demos, reviews, and walkthroughs for QIR Suite.

View all on YouTube

Frequently Asked Questions

The QIR Suite is designed for seamless integration with standard reading environments like PACS (Picture Archiving and Communication System) and HL7 servers, becoming a fully integrated solution within your daily workflow. It allows for loading, viewing, post-processing, and quantitative evaluation of cardiovascular MR and CT images in DICOM format.
Yes, the QIR Suite is a CE marked for the EU market, FDA cleared for the USA, PMDA cleared for Japan, and TFDA cleared for Taiwan, indicating its adherence to international regulatory standards as a medical device software. While it provides quantitative analysis for diagnosis, specific features for MIPS or other quality reporting directly within the suite are not explicitly detailed in the provided information, but its analytical capabilities can support such efforts.
The QIR Suite distinguishes itself through its AI-based automatic detection and deep learning algorithms for swift and accurate analysis of cardiovascular MR and CT images. It offers features like automatic segmentation and quantification of over 100 clinical parameters, aiming to reduce physician workload and save time. A notable difference from some alternatives like Segment CMR is its validation for adult patients only.
The QIR Suite offers flexible pricing models, including a one-time license fee or a subscription. The cost can be based on factors such as the number of analyses performed, the number of installations required, or the number of users accessing the software.
The QIR Suite is intended for use by qualified medical professionals experienced in interpreting cardiovascular images and is validated specifically for adult patients. It serves as a clinical decision support tool and cannot replace the final diagnosis of a qualified practitioner or be considered a sole medical point-of-view, particularly in highly complex or rare cases.
As an FDA-cleared medical device that handles patient health information and integrates with PACS and HL7 servers, the QIR Suite is expected to adhere to stringent data security and privacy regulations. While specific HIPAA compliance mechanisms like encryption or access controls are not explicitly detailed in the provided information, such measures are standard for medical software handling protected health information in the USA.
The software ergonomics of the QIR Suite have been optimized based on clinician feedback, aiming for an intuitive interface that saves time and reduces workload. While explicit details on formal training programs are not provided in the search results, the company CASIS, as the developer, would typically offer support for its medical device software.

Compare QIR Suite

VS
QIR Suite vs EchoNext
Cardiology AI Adjacent · 65/100
These tools are adjacent competitors, both focusing on cardiovascular AI but with different diagnostic approaches. QIR Suite excels in detailed quantitative analysis of MR and CT images for…
VS
QIR Suite vs V7 Diagnostic Ultrasound System
Cardiology AI Adjacent · 65/100
QIR Suite is an AI-based software focused on analyzing existing MR and CT images for cardiovascular conditions, providing quantitative evaluations. In contrast, the Samsung V7 Diagnostic Ultrasound System…
VS
QIR Suite vs CardIQ Suite
Cardiology AI Adjacent · 70/100
QIR Suite offers AI-based quantitative analysis for both cardiac MR and CT images, focusing on parameters like blood flow, perfusion, and strain. In contrast, CardIQ Suite is a…
VS
QIR Suite vs Lung AI
Cardiology AI Adjacent · 65/100
QIR Suite is an AI-based software for detailed quantitative analysis of cardiovascular conditions using MR and CT images, deployed locally. Lung AI, conversely, is an integrated handheld ultrasound…

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.